PATENT CLAIM ANALYSIS

Application Number: 15750704
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "211150"]

Abstract:
FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.

Claim (Index 15):
A method for treating cancers in a subject in need thereof, comprising administering an effective amount of the pharmaceutical composition according to  claim 13  to the subject.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 88.0
- Lexical Diversity: 1.44
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15548776', '16470111', '15812142', '15314599', '16317510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884284958466199
- 35 USC 102 Novelty (BERT): 0.5231916600173125
- Combined Prediction Score: 0.7619048122636892
- Mean Citation Score: 329.67529
- Max Citation Score: 341.71124
- Similarity Product: 272.8906635258865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test